tiprankstipranks
Arovella Therapeutics Limited (DE:E4NA)
FRANKFURT:E4NA
Germany Market
E4NA
Arovella Therapeutics Limited
RESEARCH TOOLSreports

Arovella Therapeutics Limited (E4NA) Ratios

0 Followers

Arovella Therapeutics Limited Ratios

DE:E4NA's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, DE:E4NA's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 17.51 17.51 14.18 6.45 3.10
Quick Ratio
 17.51 17.51 14.18 6.45 3.10
Cash Ratio
 17.15 17.15 13.99 6.23 3.08
Solvency Ratio
 -7.93 -7.93 -4.86 -4.23 -5.53
Operating Cash Flow Ratio
 -8.25 -8.25 -4.64 -3.39 -3.80
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 13.80MAU$ 13.80MAU$ 19.65MAU$ 11.10MAU$ 3.53M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.03
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.04
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.06 1.06 1.08 1.18 1.45
Debt Service Coverage Ratio
 0.00 0.00 0.00 -1.01K -450.98
Interest Coverage Ratio
 0.00 0.00 0.00 -1.25K -468.26
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 <0.01 <0.01
Net Debt to EBITDA
 1.29 1.29 1.88 1.20 0.48
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%-152.82%-739.07%
EBIT Margin
0.00%0.00%-8237.35%-62779.56%-2761.64%
EBITDA Margin
0.00%0.00%-8158.46%-62526.75%-2555.39%
Operating Profit Margin
0.00%0.00%-8237.35%-63595.65%-2385.02%
Pretax Profit Margin
0.00%0.00%-5521.45%-51447.26%-2766.73%
Net Profit Margin
0.00%0.00%-5521.45%-51447.26%-2508.35%
Continuous Operations Profit Margin
0.00%0.00%-3092.58%-51447.26%-2508.35%
Net Income Per EBT
66.41%66.41%100.00%100.00%90.66%
EBT Per EBIT
92.87%92.87%67.03%80.90%116.00%
Return on Assets (ROA)
-46.08%-46.08%-34.76%-65.84%-186.10%
Return on Equity (ROE)
-41.83%-48.87%-37.40%-77.89%-269.34%
Return on Capital Employed (ROCE)
-79.13%-79.13%-55.71%-96.15%-255.47%
Return on Invested Capital (ROIC)
-52.55%-52.55%-31.21%-74.88%-231.62%
Return on Tangible Assets
-46.08%-46.08%-34.76%-65.84%-316.42%
Earnings Yield
-9.58%-9.29%-6.84%-6.41%-28.62%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 39.49
Payables Turnover
 0.37 0.37 0.11 0.04 4.41
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.32 0.13 8.14
Asset Turnover
 0.00 0.00 <0.01 <0.01 0.07
Working Capital Turnover Ratio
 0.00 0.00 <0.01 <0.01 0.09
Cash Conversion Cycle
 -983.15 -983.15 -3.20K -8.36K -73.60
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 9.24
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 983.15 983.15 3.20K 8.36K 82.84
Operating Cycle
 0.00 0.00 0.00 0.00 9.24
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.06 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 -175.90 -175.86 -16.78 -53.45 -2.36K
Capital Expenditure Coverage Ratio
 -175.90 -175.86 -16.78 -53.45 -2.36K
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 -44.18
Operating Cash Flow to Sales Ratio
 0.00 0.00 -50.96 -406.70 -15.76
Free Cash Flow Yield
-9.58%-9.33%-6.69%-5.16%-17.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -10.34 -10.69 -14.71 -15.61 -3.49
Price-to-Sales (P/S) Ratio
 0.00 0.00 806.76 8.03K 87.64
Price-to-Book (P/B) Ratio
 5.10 5.26 5.47 12.16 9.41
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.44 -10.72 -14.94 -19.38 -5.56
Price-to-Operating Cash Flow Ratio
 -10.45 -10.78 -15.83 -19.74 -5.56
Price-to-Earnings Growth (PEG) Ratio
 -0.76 0.73 0.55 0.45 0.39
Price-to-Fair Value
 5.10 5.26 5.47 12.16 9.41
Enterprise Value Multiple
 -5.24 -5.42 -8.01 -11.65 -2.94
Enterprise Value
 58.18M 60.12M 88.84M 123.79M 30.54M
EV to EBITDA
 -5.24 -5.42 -8.01 -11.65 -2.94
EV to Sales
 0.00 0.00 653.25 7.28K 75.25
EV to Free Cash Flow
 -8.38 -8.66 -12.10 -17.58 -4.77
EV to Operating Cash Flow
 -8.42 -8.71 -12.82 -17.90 -4.77
Tangible Book Value Per Share
 0.01 0.01 0.02 0.01 <0.01
Shareholders’ Equity Per Share
 0.01 0.01 0.02 0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.34 0.34 0.44 0.22 0.09
Revenue Per Share
 0.00 0.00 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 -0.01
Tax Burden
 0.66 0.66 1.00 1.00 0.91
Interest Burden
 0.93 0.93 0.67 0.82 1.00
Research & Development to Revenue
 0.00 0.00 47.95 396.20 9.82
SG&A to Revenue
 0.00 0.00 22.50 163.00 7.65
Stock-Based Compensation to Revenue
 0.00 0.00 6.21 61.69 2.13
Income Quality
 1.00 1.00 0.92 0.79 0.63
Currency in AUD